• Our Vision

    Better Testing. Better Treatment.
1
/
3
/

Who we are

Diaceutics is the diagnostic development and commercialization service provider.

What we do

We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network.

What we stand for

Our ultimate goal is to drive better testing to enable better treatment decisions for patients.

Who we work with

boehringer-ingelheim
merck
roche
source-bioscience
takeda
promega
bill-and-melinda-gates-foundation
neo-genomics
bluebirdbio
pfizer
lilly
novartis
abbvie
astellas
daiichi-sankyo
gilead
synlab
janssen
bristol-myers-squibb
ganymed
lexicon
astrazeneca
gsk
celgene
immunogen
bayer
incyte

Partnering with stakeholders in healthcare globally to empower patients to receive better treatments through better testing.